TEMPEST THERAPEUTICS INC TPST

US Healthcare Pharmaceutical Preparations
$1.09
-1.8%
52w: $1.05 – $11.83

Latest 13F among current holders filed 32 days ago (Jun 3, 2026)

Price — last 12 months

research preview data
1.056.4411.83
Jun 20, 2025 Jul 2, 2026
Institutional holders
22
+1 QoQ
13F value
$1.3M
-42.9% QoQ
Smart-money holders
1
signal tier ≥ 2
New smart buyers
0
Q1 2026
Options barometer
puts only
— calls / $20K puts

Institutional value by quarter

$38.8M
Q1 2024
$4.7M
Q2 2024
$3.9M
Q3 2024
$5.7M
Q4 2024
$4.4M
Q1 2025
$6.4M
Q2 2025
$6.0M
Q3 2025
$2.3M
Q4 2025
$1.3M
Q1 2026

Number of holders

31
Q1 2024
25
Q2 2024
29
Q3 2024
36
Q4 2024
25
Q1 2025
19
Q2 2025
17
Q3 2025
21
Q4 2025
22
Q1 2026

Who owns TPST?

Q1 2026 filings
FundTypeSharesValue% of fundChange
Versant Venture Management, LLC ★2Fundamental diversified269.8K$442K0.3%Held
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical233.9K$384K0.0%
GEODE CAPITAL MANAGEMENT, LLC Index provider87.0K$143K0.0%+97.2%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical68.9K$113K0.0%
BlackRock, Inc. Index provider39.1K$64K0.0%Held
FMR LLC Long only active33.2K$54K0.0%Held
SABBY MANAGEMENT, LLC Other17.9K$29K0.5%-90.0%
NORTHERN TRUST CORP Index provider14.1K$23K0.0%Held
DIMENSIONAL FUND ADVISORS LP Quant stat arb11.4K$19K0.0%Held
UBS Group AG Bank broker4.5K$7K0.0%-74.2%
Tower Research Capital LLC (TRC) Market maker2.8K$5K0.0%+110.6%
MORGAN STANLEY Bank broker2.1K$3K0.0%Held
OSAIC HOLDINGS, INC. Wealth advisor1.5K$2K0.0%-5.2%
Federation des caisses Desjardins du Quebec Diversified mechanical292$4790.0%Held
JONES FINANCIAL COMPANIES LLLP Wealth advisor239$4130.0%Held
Vanguard Global Advisers, LLC Diversified mechanical168$2760.0%
SBI Securities Co., Ltd. Diversified mechanical56$920.0%Held
Parallel Advisors, LLC Wealth advisor18$300.0%Held
CITIGROUP INC Bank broker8$130.0%New
JPMORGAN CHASE & CO Bank broker5$80.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker3$50.0%Held
ROYAL BANK OF CANADA Bank broker27$00.0%+237.5%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.